Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 2/20 | 0.71 |
| ▸ | CES1 | P23141 | 2/20 | 0.71 |
| ▸ | PARP1 | P09874 | 1/20 | 0.65 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.62 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.61 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.61 |
| ▸ | CA12 | O43570 | 1/20 | 0.58 |
| ▸ | CA1 | P00915 | 1/20 | 0.58 |
| ▸ | CA2 | P00918 | 1/20 | 0.58 |
| ▸ | CA6 | P23280 | 1/20 | 0.58 |
| ▸ | CA9 | Q16790 | 1/20 | 0.58 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.57 |
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
| ▸ | KCNK3 | O14649 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.55 |
| ▸ | HPGD | P15428 | 2/20 | 0.54 |
| ▸ | KMO | O15229 | 1/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13950378 | 1.00 | CES2 (0.71) | CES2CES1PARP1L3MBTL1HDAC1 | |
| SCHEMBL28396 | 1.00 | CES2 (0.71) | CES2CES1PARP1L3MBTL1HDAC1 | |
| Hydrochloric Acid SCHEMBL5777634 | 0.98 | CES2 (0.68) | CES2CES1PARP1L3MBTL1HDAC1 | |
| Lithium SCHEMBL30901907 | 0.98 | CES2 (0.68) | CES2CES1PARP1L3MBTL1HDAC1 | |
| SCHEMBL11459100 | 0.98 | CES2 (0.68) | CES2CES1PARP1L3MBTL1HDAC1 | |
| Hydrochloric Acid SCHEMBL30596526 | 0.98 | CES2 (0.68) | CES2CES1PARP1L3MBTL1HDAC1 | |
| SCHEMBL28208655 | 0.98 | CES2 (0.68) | CES2CES1PARP1L3MBTL1HDAC1 | |
| Water SCHEMBL10357175 | 0.96 | CES2 (0.65) | CES2CES1PARP1L3MBTL1HDAC1 | |
| Methyl Alcohol SCHEMBL27893546 | 0.96 | CES2 (0.65) | CES2CES1PARP1L3MBTL1HDAC1 | |
| SCHEMBL15268423 | 0.94 | CES2 (0.63) | CES2CES1PARP1L3MBTL1HDAC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025262221-A1 | BIOLOGICALLY-PRODUCED FLUORINATED MONOMERS AND POLYMERS | BIOHALO APS (DK) | 2025-12-26 | — | — | WO | claimed |
| CN-117550981-B | Preparation method of 2-amino-5-fluoro acetophenone | 成都工业学院 | 2024-03-15 | — | — | CN | claimed |
| CN-117550981-A | Preparation method of 2-amino-5-fluoro acetophenone | 成都工业学院 | 2024-02-13 | — | — | CN | claimed |
| WO-2023149908-A1 | ORGANIC ESTERS WITH ELECTRON WITHDRAWING GROUPS FOR USE IN SUBTERRANEAN FORMATIONS | HALLIBURTON ENERGY SERVICES, INC. (US) | 2023-08-10 | — | — | WO | claimed |
| EP-4176052-A1 | BACTERIAL CELLS AND METHODS FOR PRODUCTION OF 2-FLUORO-CIS,CIS-MUCONATE | Danmarks Tekniske Universitet (DK) | 2023-05-10 | — | — | EP | claimed |
| EP-3438108-B1 | PHENYL [A]INDOLE[2,3-G]QUINOLIZINE COMPOUNDS, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION, AND APPLICATIONS THEREOF | SHANGHAI INST MATERIA MEDICA CAS (CN) | 2022-08-10 | — | — | EP | claimed |
| EP-4683923-A1 | HYDROGEN SULFATE COMPLEXES, INCLUDING SALTS, CRYSTALLINE FORMS, AND HYDRATES AND SOLVATES OF ENT1 INHIBITORS | iTeos Belgium SA (BE) | 2026-01-28 | — | — | EP | disclosed |
| EP-4680602-A1 | HETEROCYCLIC COMPOUNDS AS SELECTIVE HDAC6 INHIBITORS | Miralinc Pharma, Inc. (US) | 2026-01-21 | — | — | EP | disclosed |
| EP-4658667-A1 | CYCLIC PEPTIDES FOR INHIBITING TNF RECEPTOR 1 ACTIVITY | Merck Sharp & Dohme LLC (US) | 2025-12-10 | — | — | EP | disclosed |
| EP-4634196-A1 | PERACID PROMOTERS IN THE IRIDIUM-CATALYZED HYDROSILYLATION SYNTHESIS OF HALOALKYLORGANOSILANES | Momentive Performance Materials GmbH (DE) | 2025-10-22 | — | — | EP | disclosed |
| EP-4612134-A1 | DIARYL DIAZOLE AND DIARYL TRIAZOLE DERIVATIVES FOR USE IN TREATING A DISEASE ASSOCIATED WITH KCNK13 ACTIVITY | Cerevance, Inc. (US) | 2025-09-10 | — | — | EP | disclosed |
| CN-117402055-B | Resource utilization method of 2, 4-dichloro-5-fluoroacetophenone mother liquor | 浙江吉泰新材料股份有限公司 | 2024-10-29 | — | — | CN | disclosed |
| CN-117402055-B | Resource utilization method of 2, 4-dichloro-5-fluoroacetophenone mother liquor | 浙江吉泰新材料股份有限公司 | 2024-10-29 | — | — | CN | disclosed |
| EP-4143195-A1 | IMIDAZOPYRIDAZINES AS MODULATORS OF IL-17 | Janssen Pharmaceutica NV (BE) | 2023-03-08 | — | — | EP | disclosed |
| US-20220340893-A1 | BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES | NUEVOLUTION A/S (DK) | 2022-10-27 | — | — | US | disclosed |
| EP-3328843-B1 | 1,3,4-OXADIAZOLE SULFONAMIDE DERIVATIVE COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND THE PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | CHONG KUN DANG PHARMACEUTICAL CORP (KR) | 2022-10-26 | — | — | EP | disclosed |
| EP-4069252-A1 | PDIA4 INHIBITORS AND USE THEREOF FOR INHIBITING SS-CELL PATHOGENESIS AND TREATING DIABETES | Academia Sinica (CN) | 2022-10-12 | — | — | EP | disclosed |
| WO-2022180080-A1 | ANTI-PROLIFERATIVE AGENTS | FIRST HEALTH PHARMACEUTICALS B.V. (NL) | 2022-09-01 | — | — | WO | disclosed |
| EP-3438108-B1 | PHENYL [A]INDOLE[2,3-G]QUINOLIZINE COMPOUNDS, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION, AND APPLICATIONS THEREOF | SHANGHAI INST MATERIA MEDICA CAS (CN) | 2022-08-10 | — | — | EP | disclosed |
| WO-2022124246-A1 | RECESS ETCHING SOLUTION, RECESS ETCHING METHOD, AND SURFACE-TREATED SEMICONDUCTOR SUBSTRATE MANUFACTURING METHOD | 三菱瓦斯化学株式会社 | 2022-06-16 | — | — | WO | disclosed |